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Splice variant–specific cellular function of the 
formin INF2 in maintenance of Golgi architecture
Vinay Ramabhadrana, Farida Korobovaa, Gilbert J. Rahmeb, and Henry N. Higgsa
aDepartment of Biochemistry, Dartmouth Medical School, Hanover NH 03755; bNorris Cotton Cancer Center, 
Dartmouth Medical School, Lebanon NH 03766
ABSTRACT INF2 is a unique formin that can both polymerize and depolymerize actin fila-
ments. Mutations in INF2 cause the kidney disease focal and segmental glomerulosclerosis. 
INF2 can be expressed as two C-terminal splice variants: CAAX and non-CAAX. The CAAX 
isoform contains a C-terminal prenyl group and is tightly bound to endoplasmic reticulum 
(ER). The localization pattern and cellular function of the non-CAAX isoform have not been 
studied. Here we find that the two isoforms are expressed in a cell type–dependent manner, 
with CAAX predominant in 3T3 fibroblasts and non-CAAX predominant in U2OS, HeLa, and 
Jurkat cells. Although INF2-CAAX is ER localized in an actin-independent manner, INF2–non-
CAAX localizes in an actin-dependent meshwork pattern distinct from ER. INF2–non-CAAX is 
loosely attached to this meshwork, being extracted by brief digitonin treatment. Suppression 
of INF2–non-CAAX causes fragmentation of the Golgi apparatus. This effect is counteracted 
by treatment with the actin monomer–sequestering drug latrunculin B. We also find discrete 
patches of actin filaments in the peri-Golgi region, and these patches are reduced upon INF2 
suppression. Our results suggest that the non-CAAX isoform of INF2 serves a distinct cellular 
function from that of the CAAX isoform.
INTRODUCTION
Formin proteins comprise a class of actin assembly factors that ac-
celerate actin filament nucleation and modulate filament elongation 
rate (Kovar, 2006; Chesarone et al., 2010). There are 15 mammalian 
formins, which can be classified into seven different phylogenetic 
groups (Higgs and Peterson, 2005). A key feature of all formins is the 
presence of the formin homology 1 (FH1) and formin homology 2 
(FH2) domains, which are necessary for actin nucleation acceleration 
and subsequent regulation of barbed-end elongation (Kovar and 
Pollard, 2004; Higgs, 2005). A subset of formins, termed Diapha-
nous-related formins (Drfs), are postulated to be regulated by an 
autoinhibitory interaction between an N-terminal Diaphanous in-
hibitory domain (DID) and a C-terminal Diaphanous autoregulatory 
domain (DAD). For at least some Drfs, Rho GTPases relieve this au-
toinhibition by binding a region overlapping the DID. Recent stud-
ies have implicated formins as playing a key role in many cellular 
functions, including intracellular transport, cytokinesis, and cell mi-
gration (Campellone and Welch, 2010).
INF2 is a unique Drf formin that can accelerate both actin polym-
erization and depolymerization (Chhabra and Higgs, 2006). INF2’s 
depolymerization activity depends on the DAD, which also acts as a 
WH2-like actin monomer–binding motif. Despite possessing both 
DID and DAD, INF2 appears to have altered regulatory properties, 
since DID is ineffective at inhibiting actin polymerization (Chhabra 
et al., 2009). INF2 is particularly interesting in view of its role in the 
kidney disease focal and segmental glomerulosclerosis (FSGS). Mu-
tations in the DID of INF2 strongly correlate with FSGS in a number 
of families (12–17%) afflicted with this disease (Brown et al., 2010; 
Boyer et al., 2011; Gbadegesin et al., 2011; Lee et al., 2011). The 
cells affected in FSGS are podocytes—epithelial cells in the glomer-
ulus—whose actin-rich foot processes are vital for appropriate glom-
erular filtration (Faul et al., 2007).
Despite the clear correlation between INF2 and FSGS, the cel-
lular role of INF2 is incompletely understood. In Swiss 3T3 fibro-
blasts, INF2 is tightly bound to endoplasmic reticulum (ER), an inter-
action that depends upon its C-terminal prenylation (Chhabra et al., 
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2009). Suppression of INF2 expression does not noticeably alter ER 
morphology, but overexpression of an INF2 DAD/WH2 mutant 
causes massive ER-associated actin polymerization and ER collapse 
(Chhabra et al., 2009).
Recently there have been interesting reports on the cellular roles 
of INF2. Alonso and colleagues have shown that INF2 interacts with 
MAL proteins—integral membrane proteins that reside on Golgi and 
endosomal membranes (Puertollano and Alonso, 1999; de Marco et 
al. 2002). In hepatocyte-derived HepG2 cells, INF2 knockdown in-
hibits MAL2-dependent transcytosis (Madrid et al., 2010). In Jurkat 
leukemic T cells, INF2 knockdown inhibits MAL-dependent post-
Golgi trafficking of Lck to the plasma membrane (Andres-Delgado et 
al., 2010). These functions are inconsistent with INF2 localization to 
ER, raising questions about the role of INF2 in these processes.
One possibility is that splice variants of INF2 have distinct cellular 
functions. INF2 has two C-terminal splice variants: the CAAX variant, 
with its C-terminal prenylation site that is critical for stable ER asso-
ciation (Chhabra et al., 2009), and the non-CAAX variant, which is 
not predicted to be posttranslationally modified (Figure 1). The lo-
calization pattern and cellular function of INF2–non-CAAX are not 
known. To understand the cellular and physiological role of INF2 in 
greater detail, it is important to elucidate differences in properties 
and roles of these two splice variants.
In this study, we show that the two splice variants of INF2 are 
expressed in a cell type–dependent manner. The CAAX and non-
CAAX variants localize differently in cells, have different membrane 
association properties, and are differentially sensitive to treatments 
with actin- and microtubule-depolymerizing drugs. We also identify 
a possible role for the non-CAAX splice variant in actin-dependent 
maintenance of Golgi morphology.
RESULTS
INF2 displays differential localization in 3T3 and U2OS cells
We previously showed that, in Swiss 3T3 cells, INF2 localizes to the 
cytoplasmic face of the ER and that this ER localization depends on 
a C-terminal prenylation signal (CAAX box). Mutation of the cysteine 
in the CAAX box leads to the mislocalization of INF2 in Swiss 3T3 
cells. We confirmed prenylation (farnesylation), as well as the two 
subsequent modifications common to prenylated proteins (pepti-
dase removal of the C-terminal three amino acids and carboxy-
methylation) of INF2 immunoprecipitated from the membrane frac-
tion of mouse brain (Figure 1B; Chhabra et al., 2009).
Given these previous results, we were surprised to find that, in 
U2OS cells, endogenous INF2 does not localize to ER but forms a 
distinct, web-like pattern. Owing to its abundance, INF2 staining 
occasionally overlaps with ER in some places but is clearly distinct 
(Figure 2A). INF2 displays similar localization in HeLa cells (Supple-
mental Figure S1A). Suppression of INF2 expression by small inter-
fering RNA (siRNA) in U2OS cells results in loss of the punctate stain-
ing pattern, confirming antibody specificity (Figure 8A). INF2 does 
localize to ER in NIH 3T3 cells (Figure 2B), similar to our previous 
results using Swiss 3T3 cells (Chhabra et al., 2009). These differ-
ences in INF2 localization between NIH 3T3 and U2OS occur re-
gardless of the ER marker used (Supplemental Figure S1B). Thus, 
INF2 displays distinct localization patterns, depending on the cell 
type.
Our previous studies showed that, in Swiss 3T3 cells, INF2 
distribution was dramatically altered by microtubule depolymer-
ization, collapsing around the nucleus in a similar manner to ER 
(Chhabra et al., 2009). Because INF2 distribution differs in U2OS 
cells, we reasoned that the effect of microtubule depolymeriza-
tion on INF2 distribution might also differ. Indeed, INF2 distri-
bution is microtubule independent in U2OS cells, as treatment 
with 30 μM nocodazole for 5 or 30 min causes extensive micro-
tubule depolymerization but does not alter INF2’s web-like dis-
tribution (Supplemental Figure S2). After 1 h of nocodazole 
treatment, the bulk of the ER is retracted from the periphery, 
whereas INF2 is largely unaltered (data not shown), suggesting 
that the INF2 localization pattern is not dependent on weak at-
tachment to ER.
In contrast, INF2 localization in U2OS cells is highly sensitive to 
drugs that cause actin depolymerization. Within 5 min of treatment 
FIGURE 1: INF2 splice variants. (A) Domain architecture of INF2. C-Terminal sequences starting at K1224 of human 
INF2. The CAAX and non-CAAX splice variants are shown in purple and green amino acids, respectively. (B) Schematic 
of posttranslational modifications associated with prenylation.
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with 1 μM latrunculin B (LatB), INF2 redistributes into donut-like 
structures in the cytoplasm (data not shown), and after 30 min INF2 
has condensed further to bright cytoplasmic puncta (Figure 3A). At 
both time points, most INF2-enriched areas 
are also enriched for actin filaments, as 
judged by tetramethylrhodamine isothiocy-
anate (TRITC)–phalloidin staining. Actin 
stress fibers are still abundant at the 5-min 
time point, whereas, after 30 min of LatB 
treatment, cells are largely devoid of stress 
fibers but maintain brightly staining TRITC-
phalloidin puncta of varying size. In 82% of 
the cases, TRITC-phalloidin puncta and 
INF2 puncta colocalize, with only 10% of 
INF2 puncta containing no TRITC-phalloidin 
enrichment and only 8% of TRITC-phalloidin 
puncta containing no INF2 enrichment 
(pooled data from two experiments show-
ing similar results, 184 puncta counted). Cy-
tochalasin D treatment has similar effects 
(Supplemental Figure S3). This result con-
trasts with our observations in Swiss 3T3 
cells, in which LatB treatment does not 
change INF2 localization significantly 
(Chhabra et al., 2009). Further examination 
of INF2 and phalloidin staining in confocal 
sections through the middle region of the 
cytoplasm suggests that the INF2 meshwork 
pattern overlaps with apparent actin filament staining that is distinct 
from the stress fiber staining that dominates the ventral regions of 
the cell (Figure 3B).
Our combined results show that INF2 
distribution in U2OS cells is distinct from 
that in 3T3 cells, localizing in an actin-de-
pendent, web-like pattern distinct from ER.
Cell line–specific expression patterns 
of INF2 splice variants
In addition to the prenylated version (INF2-
CAAX), a second INF2 splice variant (INF2–
non-CAAX) has been identified in cDNA li-
braries. INF2–non-CAAX contains an altered 
C-terminal region, with the 18–amino acid 
CAAX C-terminus being swapped for a 
nine–amino acid non-CAAX sequence that 
does not contain a prenylation sequence 
(Figure 1). We hypothesized that INF2’s C-
terminal splice variation might play a role in 
its cell type–specific localization. To test this 
hypothesis, we raised antibodies against 
INF2 CAAX and non-CAAX C-terminal 
peptides and performed Western blot anal-
ysis for these splice variants. Owing to the 
number of amino acid differences between 
the mouse and human proteins in the C-
terminal region (five of 15 residues in CAAX, 
one of nine in non-CAAX), we produced 
separate antibodies to the human and 
mouse C-termini. Each antibody is specific 
for its peptide epitope, as it does not detect 
overexpressed green fluorescent protein fu-
sion of the opposite isoform (Figure 4).
In NIH 3T3 cell lysates, a strong 
Western band for the CAAX isoform is 
present, whereas the non-CAAX isoform is 
FIGURE 2: INF2 does not localize to ER in U2OS cells. (A) U2OS cells transfected with mCherry-
Sec61β (an ER membrane protein; red) and stained with anti-INF2 antibody (green) and DAPI 
(blue). (B) NIH 3T3 cells stained with anti-INF2 (green), anti-GRP94 (an ER luminal protein; red) 
and DAPI (blue). See Supplemental Figure S1B for analogous INF2/ER localization using the ER 
marker. Scale bar, 20 μm.
FIGURE 3: Actin depolymerization causes INF2 aggregation in U2OS cells. (A) U2OS cells were 
treated with 1 μM LatB for 0 and 30 min prior to fixation and staining with anti-INF2 (green), 
TRITC-phalloidin (red), and DAPI (blue). Arrow indicates one such actin aggregate where INF2 
colocalizes. Scale bar, 20 μm. (B) Single confocal slice of U2OS cells stained with anti-INF2 
(green) and rhodamine-phalloidin (red). Arrows show examples of regions where INF2 and actin 
filaments colocalize. Scale bars: 5 μm (leftmost three images) and 20 μm (rightmost image).
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undetectable, suggesting that the CAAX isoform predominates in 
these cells (Figure 4A). We carried out similar analysis of HeLa and 
Jurkat lysates. In contrast to 3T3 cells, both HeLa and Jurkat lysates 
show clear bands for the non-CAAX isoform, with very little CAAX 
isoform (Figure 4B).
We conducted similar analysis on U2OS cells, with two varia-
tions: 1) as positive controls, we used U2OS cells stably transfected 
with GFP-INF2-CAAX or GFP-INF2–non-CAAX, and 2) we immu-
noprecipitated INF2 from lysates using an antibody against the 
FH2 domain prior to Western blotting to increase detection sensi-
tivity. The immunoprecipitations (IPs) were conducted after rapid 
denaturation of total cell protein (see Materials and Methods) to 
prevent proteolysis. No detectable INF2 staining is present in the 
supernatants from these IPs (data not shown), suggesting that the 
IPs reflect the vast majority of INF2. U2OS cells show strong en-
dogenous INF2 in the IP from untransfected U2OS cells, as well as 
from the stably expressing CAAX IP. These bands are also promi-
nent when probed with the non-CAAX antibody. In contrast, there 
is no detectable band with the CAAX antibody (Figure 4C). This 
result suggests that the non-CAAX isoform predominates in these 
cells. Of interest, we cannot detect endogenous INF2 in the stable 
GFP–non-CAAX cell line, suggesting that overexpression of the 
non-CAAX variant causes down-regulation of endogenous INF2 
protein levels.
To summarize, expression of INF2 iso-
forms appears to occur largely in an “either/
or” manner, with 3T3 cells expressing mainly 
the CAAX isoform and U2OS, HeLa, 
and Jurkat cells expressing mainly the non-
CAAX isoform. Of interest, despite unde-
tectable expression of the INF2-CAAX pro-
tein in U2OS and Jurkat cells, RT-PCR 
analysis shows that both CAAX and non-
CAAX messages are present (Supplemental 
Figure S4A).
We probed two mouse tissues with 
CAAX and non-CAAX antibodies: brain, 
since INF2 expression is high in this tissue 
(Chhabra et al., 2009), and kidney, since 
INF2 mutations result in the kidney disease 
FSGS (Brown et al., 2010). IPs of denatured 
whole-tissue extracts show that both 
CAAX and non-CAAX variants exist in 
mouse brain. In kidney, the CAAX variant is 
the predominant isoform, whereas the non-
CAAX isoform is detectable but extremely 
weak (Supplemental Figure S4B).
The CAAX and non-CAAX isoforms 
differ in membrane association 
properties
Our immunofluorescence results show that 
INF2 does not localize to ER in U2OS cells 
but does display web-like staining, sugges-
tive of binding to cellular structures such as 
membranes (Figure 2). Previously, we found 
that INF2 was stably associated with ER 
membranes in Swiss 3T3 cells, maintaining 
constant levels even after 120 min of digi-
tonin permeabilization prior to fixation 
(Chhabra et al., 2009). We conducted similar 
analysis on endogenous INF2 in U2OS cells, 
using mCherry-tagged Sec61β as an integral membrane protein 
control. In contrast to Swiss 3T3 cells, INF2 is depleted from digi-
tonin-permeabilized U2OS cells almost completely within 5 min. At 
30 min, there is no detectable INF2 left within cells (Figure 5). This 
result is similar to that obtained for GFP in these cells (data not 
shown). In contrast, Sec61β is retained on ER membranes through-
out the experiment. Our conclusion is that, whereas the CAAX iso-
form is stably bound to the ER membrane, the non-CAAX isoform is 
loosely associated with a web-like meshwork in the cytoplasm.
To test membrane association further, we subjected cell lysates 
to differential centrifugation, creating low-speed pellet (LSP, 2000 × 
g), high-speed pellet (HSP, 436,000 × g), and high-speed superna-
tant (HSS) fractions. In NIH 3T3 cells, INF2 partitions primarily in the 
pellet fractions, distributing evenly between the LSP and the HSP, 
with only 3% in the HSS (Supplemental Figure S5, A and B). Probing 
for the CAAX isoform gives a similar distribution, whereas the non-
CAAX isoform is undetectable even when the blot is overexposed 
and overprocessed. Calnexin, an ER transmembrane protein, also 
fractionates evenly between the LSP and HSP, confirming the pres-
ence of the ER in these fractions. Tubulin, however, is almost entirely 
in the HSS, suggesting that material in the LSP is not a result of in-
complete cell lysis during homogenization. These results are similar 
to our previous fractionation of Swiss 3T3 cells (Chhabra et al., 
2009).
FIGURE 4: 3T3 cells express INF2-CAAX, whereas U2OS, Jurkat, and HeLa cells express 
INF2–non-CAAX. (A) Western blots of whole-cell homogenates from NIH 3T3 cells. CAAX and 
non-CAAX controls are from U2OS cells transiently transfected with GFP-tagged mouse INF2 
isoforms. Western blots were probed with antibodies specific for total mouse INF2, INF2-CAAX, 
or INF2–non-CAAX. (B) Similar analysis as in A, using homogenates from Jurkat and HeLa cells. 
CAAX and non-CAAX controls are from U2OS cells transiently transfected with GFP-tagged 
human INF2 isoforms. (C) Western blots of immunoprecipitations of denatured lysates from 
U2OS cells either untransfected or stably expressing GFP-INF2-CAAX or GFP-INF2–non-CAAX. 
Immunoprecipitations were conducted using the total INF2 antibody. Western blots were 
probed with total INF2, INF2-CAAX, or INF2–non-CAAX antibodies. E, endogenous INF2; 
G, GFP INF2.
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We conducted similar fractionation in HeLa and Jurkat cells, 
which express primarily the non-CAAX isoform (Supplemental Fig-
ure S5, C and D). In contrast to NIH 3T3 cells, 80% of INF2 is in the 
LSS, with only 20% in the LSP in both HeLa and Jurkat cells. Frac-
tionation of the LSS reveals that 66.67% of the INF2 is in the HSS 
and 33.33% is in the HSP. Westerns for CAAX and non-CAAX iso-
forms suggest that the non-CAAX is overwhelmingly predominant in 
the HSS and HSP, with no CAAX variant detectable. The LSP fraction 
contains a CAAX-reactive band but no apparent non-CAAX band in 
both cases, suggesting that both HeLa and Jurkat cells express low 
levels of CAAX variant and that this variant is tightly bound to mem-
branes. Fractionation of U2OS cells produces similar results, albeit 
under different extraction conditions (Supplemental Figure S5E). 
These findings suggest that the CAAX and the non-CAAX isoforms 
are fundamentally different in terms of membrane association.
We previously showed that a GFP fusion of the INF2-CAAX iso-
form localizes to ER in Swiss 3T3 cells. We wondered whether we 
would obtain similar results in U2OS cells, since these cells express 
very low levels of INF2-CAAX. In U2OS cells stably expressing GFP-
INF2-CAAX, this isoform localizes to ER tubules, which is best ap-
preciated in the peripheral ER (Figure 6A). In contrast, the stable 
GFP-INF2–non-CAAX U2OS line displays evenly distributed GFP 
levels throughout the cytoplasm (Figure 6A), somewhat different 
from the web-like appearance of endogenous INF2 (Figure 2). Nei-
ther ER nor Golgi is strongly perturbed in the GFP-INF2-CAAX or 
GFP-INF2–non-CAAX cell line (data not shown). Transient expres-
sion of GFP-INF2-CAAX and GFP-INF2–non-CAAX in NIH 3T3 cells 
provides similar results, in that the CAAX variant localizes to ER, 
whereas the non-CAAX variant localizes diffusely. Also similar to 
U2OS cells, overexpression of these proteins does not perturb ER or 
Golgi structure in NIH 3T3 cells (data not shown).
Using the digitonin permeabilization technique, we find that 
GFP-INF2-CAAX is retained on ER, whereas GFP-INF2–non-CAAX 
is rapidly depleted (Figure 6B). On LatB treatment, GFP-INF2–non-
CAAX behaves similarly to endogenous INF2 in U2OS cells, redis-
tributing to actin-rich puncta (Figure 6C), 
with 94% of INF2 puncta colocalizing with 
TRITC-phalloidin puncta (pooled data from 
two experiments showing similar results, 
294 puncta counted). Overall, N-terminal 
GFP fusions of INF2-CAAX and INF2–
non-CAAX recapitulate the properties of the 
endogenous proteins.
We next asked what aspect of the C-ter-
minus dictates INF2 localization: the pres-
ence of the farnesyl modification in the 
CAAX variant, or specific sequence informa-
tion present in the non-CAAX C-terminus. 
To test this distinction, we used a GFP-INF2-
CAAX mutant in the prenylated C-terminal 
cysteine (C1246S). As found in Swiss 3T3 
cells (Chhabra et al., 2009), the C1246S mu-
tant localizes diffusely in the cytoplasm. 
Treatment with LatB causes condensation of 
C1246S to actin-rich puncta in a manner in-
distinguishable from GFP-INF2–non-CAAX 
(Figure 6C). This result suggests that the cru-
cial factor for INF2 localization is the prenyl 
motif, and absence of this modification 
causes localization similar to the non-CAAX 
isoform.
INF2 knockdown causes Golgi dispersal 
in an actin-dependent manner
INF2 interacts with MAL and MAL2, integral membrane proteins 
that localize to endosomal and trans-Golgi–derived vesicles as well 
as to the Golgi itself (Millan et al., 1997; Puertollano and Alonso, 
1999; Andres-Delgado et al., 2010; Madrid et al., 2010). For this 
reason, we examined INF2 localization in U2OS cells in more detail 
by acquiring confocal images of multiple z-sections. This examina-
tion shows that although INF2 staining is spread throughout the 
cytoplasm, it is often enriched in similar regions as the endosomal 
proteins Rab5a and Rab7a (Supplemental Figure S6). It is worth em-
phasizing that, although INF2 enrichment is in the same general 
area as these endosomal markers, close examination shows no clear 
evidence for localization to endosomal membranes.
The position of INF2 enrichment also coincides often with the 
position of the Golgi in U2OS cells (Figure 7). Despite this apparent 
enrichment around the Golgi, INF2 does not appear to be strongly 
associated with the Golgi, as evidenced by the following treatments. 
Brefeldin A or nocodazole causes dramatic Golgi dispersal but does 
not result in significant INF2 redistribution (Figure 7B and Supple-
mental Figure S6). In contrast, LatB treatment causes INF2 redistri-
bution to actin-rich puncta that do not systematically colocalize with 
the Golgi (Supplemental Figure S6).
The enrichment of INF2 in the peri-Golgi region, as well as previ-
ous evidence for interactions between actin and the Golgi (Fucini 
et al., 2000; Dubois et al., 2005; Dippold et al., 2009), prompted us 
to test the effect of INF2 knockdown on Golgi morphology. To 
quantify these results, we collected confocal z-stacks of the cis-Golgi 
marker GM130 and classified Golgi morphology into three catego-
ries: compact, spread, and dispersed (Figure 8C), as discussed in 
Materials and Methods. These categories are best appreciated in 
three-dimensional (3D) reconstructions of the z-stacks (Supplemen-
tal Movies S1–S3).
INF2 knockdown causes Golgi dispersal in U2OS cells. The ma-
jority of control U2OS cells have compact Golgi (58%), with a low 
FIGURE 5: INF2 is rapidly extracted from U2OS cells. U2OS cells were permeabilized with 
digitonin on ice for 0, 5, and 30 min before fixation. The cells were then stained with anti-INF2 
antibody (green) to detect endogenous INF2 and DAPI (blue). mCherry-Sec61β (red) was used 
as an ER membrane marker. Scale bar, 20 μm.
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percentage of dispersed Golgi (15%). Two 
distinct INF2 siRNAs, each inducing >80% 
knockdown (Figure 8B), cause a 2.5-fold 
drop in compact Golgi and a concomitant 
increase in dispersed Golgi (Figure 8D). 
Costaining knockdown cells with GM130 
(a cis-Golgi protein) and golgin-97 (a trans-
Golgi protein) reveals that the cis- and 
trans-Golgi remain associated in most of 
the dispersed Golgi fragments (Supplemen-
tal Figure 7). Similar results are obtained in 
HeLa cells (data not shown).
In NIH 3T3 cells, which express the CAAX 
isoform, the Golgi is inherently more dis-
persed than in U2OS cells, with 22% com-
pact, 27% spread, and 51% dispersed in 
control cells. INF2 knockdown does not re-
sult in significant changes to the degree of 
Golgi dispersion (Supplemental Figure S8), 
suggesting that the CAAX isoform does not 
influence Golgi distribution.
We examined these effects of INF2 
knockdown on the Golgi in more detail by 
quantifying the size of the Golgi compart-
ment (Supplemental Figure S7B). To quan-
tify the amount of Golgi membrane, we 
summed the total volume of GM130-stained 
structures from 3D reconstructions of z-
stacks. To quantify the degree of Golgi 
spreading, we traced the perimeter of Golgi 
membranes from maximum intensity projec-
tions of z-stacks, resulting in an area includ-
ing Golgi membranes and interspersed cy-
tosol. We conducted similar measurements 
on nuclear volume and area from 4′,6-diami-
dino-2-phenylindole (DAPI) stain. These 
measurements show that INF2 knockdown 
in U2OS cells causes a slight decrease in 
Golgi membrane volume (63.1 ± 8.7 μm3 for 
control vs. 52.7 ± 4.9 and 55.4 ± 3.3 μm3 for 
INF2 knockdown) but an expansion of the 
Golgi spread area (87.5 ± 23.2 μm2 for con-
trol vs. 126.9 ± 19.4 and 144.5 ±13.2 μm2 
for INF2 knockdown). In NIH 3T3 cells, the 
Golgi occupies a significantly greater 
area (164.86 ± 19.5 μm2, 1.88-fold increase) 
FIGURE 6: Stably transfected U2OS cells lines expressing GFP-INF2-CAAX and GFP-INF2–non-
CAAX recapitulate endogenous proteins. (A) Localization of GFP-INF2-CAAX and GFP-INF2–
non-CAAX in U2OS cells. mCherry-Sec61β (red) was used as an ER marker. Scale bar, 10 μm. 
mCherry-Sec61β was overexposed to 
visualize the peripheral ER. (B) Digitonin 
permeabilization of U2OS INF2-CAAX and 
non-CAAX stable cell lines. The cells were 
permeabilized for 0, 5, or 30 min on ice 
before fixation. Scale bar, 20 μm. (C) Effect of 
LatB on GFP-INF2-CAAX (C1246S) mutant 
and GFP-INF2–non-CAAX. U2OS cells were 
transfected with mouse GFP-INF2-CAAX 
mutant or GFP-INF2–non-CAAX treated with 
1 μM LatB for the indicated amount of time. 
The cells were then fixed and stained with 
TRITC phalloidin. Arrow indicates one such 
actin aggregate where INF2 colocalizes. 
Scale bar, 20 μm.
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and membrane volume (96.8 ± 13.7 μm3, 1.53-fold increase) than 
in U2OS cells, but both values decrease slightly upon INF2 knock-
down. Exogenous expression of an siRNA-resistant INF2–non-
CAAX construct causes partial rescue of the siRNA-induced Golgi 
expansion phenotype (Golgi area, 45 ± 5 μm2 for control,154 ± 
23 μm2 for INF2 knockdown, and 84 ±12 μm2 for INF2 knockdown/
reexpression).
To examine whether the Golgi dispersion observed upon INF2 
knockdown depends on the actin cytoskeleton, we treated control 
and INF2-depleted U2OS cells with LatB prior to examination of 
Golgi morphology. In control cells, LatB treatment results in elimina-
tion of dispersed Golgi and a large reduction in spread Golgi (Figure 
8E) while having no apparent effect on ER morphology (data not 
shown). Golgi compaction upon LatB treatment is rapid, with no-
ticeable compaction at 10 min and full compaction occurring by 
30 min (Supplemental Figure S7B). Even 
though total cell area also shrinks during this 
time course (Supplemental Figure S7), the 
effects on Golgi do not appear to be due to 
overall shrinking of cellular area, since Golgi 
compaction occurs in cells that are still well 
spread (Supplemental Figure S7C). This ef-
fect on Golgi occurs also in INF2-depleted 
cells, which have greatly increased spread 
Golgi in the absence of LatB (Figure 8E and 
Supplemental Figure S7B). These results 
suggest that Golgi dispersion in U2OS cells 
is actin dependent and that INF2’s role is to 
counteract this actin-dependent dispersion.
One question from these results con-
cerns whether INF2 knockdown produces 
any observable effect on actin in the vicinity 
of the Golgi. To address this question, we 
costained U2OS cells with GM130 and 
TRITC-phalloidin after transfection with con-
trol siRNA or INF2 siRNA. Careful examina-
tion reveals the presence of TRITC-phalloi-
din patches apparently intermingled with 
Golgi (Figure 9A; also see Supplemental 
Movies S4 and S5 for examination of z-
stacks). These patches are largely obscured 
by ventral stress fibers in wide-field fluores-
cence images, and z-sectioning is necessary 
to view them clearly. The patches vary in size 
and intensity but are generally <1 μm in di-
ameter. On INF2 knockdown, the patches 
disperse along with Golgi, and the number 
of patches is reduced by ∼30%. Control cells 
contain 12.7 patches/Golgi (217 patches 
from 17 cells), whereas INF2 siRNA cells 
contain 9.0 patches/Golgi (190 patches from 
21 cells; two experiments conducted, both 
giving a similar 30% decrease). Costaining 
for INF2, actin filaments, and Golgi reveals 
that 72% of the patches have visible INF2 
staining (Figure 9B).
One possibility is that INF2 knockdown 
alters Golgi morphology indirectly by alter-
ing the cell cycle, since Golgi morphology 
changes during the cell cycle (Lippincott-
Schwartz and Zaal, 2000). Experiments us-
ing flow cytometric measurement of DNA 
content show no clear change in cell cycle upon INF2 knockdown 
(data not shown). To test the effects of INF2 knockdown on Golgi at 
a particular cell cycle stage, we synchronized U2OS cells by low-
dose nocodazole treatment followed by mitotic shake-off and 6 h of 
recovery, resulting in a G1-synchronized population. In these syn-
chronized cells, INF2 knockdown results in a similar increase in 
spread and dispersed cells as observed in nonsynchronized cells 
(83% compact vs. 17% spread vs. 0% dispersed cells in control [48 
cells counted] compared to 39 vs. 49 vs. 12% in INF2 siRNA1 cells 
[49 cells counted]).
DISCUSSION
In this study, we find significant differences in cellular localization, 
expression patterns, and cellular function between two splice vari-
ants of the formin INF2. The CAAX variant, which is farnesylated at 
FIGURE 7: INF2 enriches around the Golgi apparatus. (A) U2OS cells were stained with 
anti-INF2 (green) and golgin-97 (a marker for the trans-Golgi network; red). Top, one confocal 
z-section. Bottom, the maximum-intensity projection of multiple confocal z-sections. Arrow 
represents INF2 enrichment around the Golgi. Scale bar, 20 μm. (B) U2OS cells treated for 0 or 
30 min with 2.5 μg/ml brefeldin A. Arrow represents INF2 enrichment around the Golgi The cells 
were then fixed and stained with anti-INF2 (green) and anti–golgin-97 (red) antibodies. Scale bar, 
20 μm.
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its C-terminus, is stably bound to ER membranes (Chhabra et al., 
2009; the present study). Although microtubule depolymerization 
disrupts INF2-CAAX distribution (along with ER), actin depolymer-
ization has no apparent effect. In contrast, the non-CAAX variant 
displays a web-like cytoplasmic appearance that is distinct from ER. 
Although INF2-non-CAAX localization is unaffected by microtubule 
depolymerization, actin depolymerization causes collapse of INF2 
into discrete puncta that generally enrich with residual actin fila-
ments. The fact that a fraction of INF2–non-CAAX partitions to the 
pellet fraction upon differential centrifuga-
tion of cell lysates suggests that INF2–non-
CAAX is at least weakly associated with 
membranes or other pelletable cellular 
structures.
INF2 splice variants are differentially ex-
pressed in cell lines. Whereas the CAAX 
variant predominates in NIH 3T3 cells, non-
CAAX is the major variant in U2OS, HeLa, 
and Jurkat cells. Tissues such as brain and 
kidney express both variants to various de-
grees. Future experiments will determine 
whether specific cell types in these tissues 
(neurons, astrocytes, podocytes) express 
only one splice variant.
An interesting feature of INF2 expression 
is that, although U2OS cells do not express 
detectable INF2-CAAX protein, they do ex-
press both CAAX and non-CAAX mRNA. 
This finding suggests that splice variant reg-
ulation may take place at a translational 
level. Also intriguing in this regard is that our 
stably transfected GFP-INF2–non-CAAX 
U2OS cell line appears to suppress the pro-
duction of endogenous INF2–non-CAAX 
protein, whereas our stable GFP-INF2-CAAX 
U2OS line does not. These findings suggest 
possible mechanisms controlling INF2 splice 
variant expression. In this respect, it might 
be noteworthy that the mRNA for another 
formin, mDia1, is localized to the ER in a 
translation-dependent manner (Liao et al., 
2011).
The localization of INF2–non-CAAX in a 
web-like network, distinct from ER, is intrigu-
ing. INF2 is rapidly extracted from this net-
work, suggesting that it is loosely attached 
or that the network is labile. INF2 organiza-
tion in this web-like pattern is actin depen-
dent, since LatB treatment dramatically al-
ters INF2 distribution. We wonder whether 
this finding suggests an actin network in in-
terphase cells, similar to those identified 
in meiotic oocytes (Lenart et al., 2005; Li 
et al., 2008; Schuh and Ellenberg, 2008). We 
have been unable to identify actin filaments 
adopting this web-like structure using fluo-
rescent phalloidin staining, but the presence 
of abundant stress fibers complicates visual-
ization of less abundant structures. We point 
out that it is not clear at this point that the 
web-like, INF2-containing structure contains 
a membrane component.
The CAAX and non-CAAX variants also have functional differ-
ences. Knockdown of INF2 in U2OS cells, which express primarily 
the non-CAAX variant, has a dramatic effect on Golgi structure, 
causing transition from its normally compact structure to dispersed 
Golgi fragments. Of interest, these fragments appear to maintain 
association of cis and trans membranes despite their dispersal. In 
addition, the dispersed Golgi remains largely perinuclear and does 
not spread to more peripheral regions. However, we do not observe 
a change in Golgi morphology upon INF2 depletion in NIH 3T3 
FIGURE 8: INF2 depletion causes dispersal of the Golgi apparatus in U2OS cells. (A) INF2-
depleted U2OS cells stained with anti-INF2 (green) and DAPI (blue). The stars indicate cells that 
have been knocked down. Scale bar, 20 μm. (B) Western blot showing INF2 depletion using two 
different siRNAs. Tubulin was used as a loading control. (C) Representative images of compact, 
spread, and dispersed Golgi. GM130 (green) was used as the Golgi marker. DAPI is in blue. 
Scale bar, 20 μm. (D) Quantification of Golgi dispersion. The data represent the average of three 
independent experiments (n > 200 cells). Error bars, SE. (E) Quantification of Golgi morphology 
upon INF2 depletion and LatB treatment. C, control siRNA; S, INF2 siRNA. Cells were treated 
with 0, 1, or 2 μM LatB for 1 h prior to fixation.
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FIGURE 9: Peri-Golgi actin patches are reduced and dispersed in INF2 knockdown. (A) Cells 
transfected with control (top) or INF2 (bottom) siRNAs were fixed and stained with anti-GM130 
(green) and TRITC-phalloidin (red). Maximum-intensity projections of three consecutive 0.2-μm 
sections taken through the middle of Golgi region are shown. Arrows indicate actin patches 
found in close proximity to Golgi stacks. Scale bar, 10 μm. Quantification of peri-Golgi actin 
patches reveals an approximate 30% decrease in patch number upon INF2 knockdown 
(12.7 patches/Golgi in control siRNA [217 patches in 17 cells] vs. 9.0 in INF2 siRNA [190 patches 
in 21 cells]). Quantification is the result of two separate experiments that showed similar 30% 
decrease for INF2 siRNA. (B) Colocalization of INF2 with actin patches. Single confocal slice of 
U2OS stained with anti-INF2 (green), TRITC-phalloidin (red), and anti–golgin-97 (blue). Arrow 
indicates a patch that colocalizes with INF2, and arrowhead indicates a patch that does not 
colocalize with INF2. Scale bar, 5 μm.
cells, which expresses the CAAX variant predominately. The fact 
that INF2-CAAX localizes to ER and that overexpression of a mutant 
INF2-CAAX construct incapable of DID/DAD interaction or effective 
depolymerization causes ER collapse (Chhabra et al., 2009) also 
suggests a fundamentally distinct cellular function.
A growing number of studies point strongly to an association 
between actin and Golgi. There is evidence for an actin network 
surrounding portions of the Golgi (Beck and Nelson, 1998; Holleran 
and Holzbaur, 1998), and both spectrin/actin and Arp2/3 complex–
mediated actin have been identified on Golgi (Devarajan et al., 
1996; Beck et al., 1997; Chen et al., 2004). Two Arp2/3 complex 
activators, WHAMM and WAVE complex (Kondylis et al., 2007; 
Campellone et al., 2008), associate with Golgi. Colfilin also associ-
ates with the Golgi and plays a role in cargo sorting (von Blume 
et al., 2009, 2011). Finally, a number of myosins localize to Golgi 
(Allan et al., 2002), and suppression of myosin 18A causes Golgi 
compaction (Dippold et al., 2009), suggesting that this myosin 
might mediate a dispersive force for Golgi, 
although recent work suggests that Droso-
phila myosin 18A does not act as an actin-
based motor in vitro (Guzik-Lendrum et al., 
2011).
How do actin filaments influence Golgi 
structure, and what role does INF2 play in 
this process? We can envision several pos-
sible roles for INF2 in this respect, including 
the following: 1) INF2 acts to polymerize 
cytoplasmic actin, and these filaments serve 
to confine Golgi; 2) INF2 acts to depolymer-
ize actin filaments that serve as tracks for 
myosin-mediated Golgi dispersion (Dippold 
et al., 2009); or 3) a low percentage of INF2 
molecules acts directly on the Golgi to po-
lymerize or depolymerize Golgi-associated 
actin filaments. Our data provide sugges-
tions but do not distinguish clearly among 
these possibilities. First, INF2–non-CAAX 
does not noticeably associate with Golgi 
but does so in a more general meshwork 
pattern that enriches somewhat near Golgi. 
Second, the effect of INF2 knockdown on 
Golgi dispersal is counteracted by LatB 
treatment, possibly suggesting that INF2’s 
role involves actin depolymerization. Tran-
sient actin networks exist in oocytes to move 
meiotic chromosomes (Lenart et al., 2005; Li 
et al., 2008; Schuh and Ellenberg, 2008), 
and we raise the possibility that a similar 
network might exist in interphase cells. 
However, we also identify actin filament 
patches in the vicinity of the Golgi and 
show that INF2 knockdown causes dis-
persion and decrease in these patches. 
The question of how these patches might 
relate to Golgi morphology is unclear, al-
though similar patches have been identi-
fied using live-cell microscopy and actin 
filament–binding probes (Miserey-Lenkei 
et al., 2010; Almeida et al., 2011). The re-
lationship of these patches with INF2, 
which localizes in more of a meshwork 
pattern but does enrich on the majority of 
these patches, also remains to be elucidated.
Recent publications have shown that two other formins, FMNL1 
(Colon-Franco et al., 2011) and mDia1 (Zilberman et al., 2011), 
have effects on Golgi structure. The gamma splice variant of 
FMNL1 enriches strongly at Golgi, and FMNL1 suppression results 
in Golgi dispersion. In contrast, mDia1 suppression results in Golgi 
compaction, although, like INF2, mDia1 is not enriched on Golgi 
membranes. Of interest, mDia1 appears to have effects on Golgi 
fusion, with overexpression of mDia1-suppressing fusion. There 
may be a direct relationship between INF2 and mDia1, since the 
two proteins interact and since INF2 can inhibit actin polymeriza-
tion by mDia1 (Sun et al., 2011). This relationship may result in an 
intricate control of cytoplasmic actin polymerization, with one con-
sequence being control of Golgi structure. Overall, the contribu-
tions of multiple formin proteins in controlling Golgi structure is 
an intriguing subject for future research and might suggest that 
multiple actin-based processes are involved.
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It is also possible that INF2’s effects on the Golgi involve micro-
tubules, which are necessary for Golgi compaction (Cole et al., 
1996). Other formins have been shown to interact with microtubules 
(Bartolini et al., 2008; Bartolini and Gundersen, 2010), and we found 
that INF2 can both bind and bundle microtubules in vitro (Gaillard 
et al., 2011).
Our findings add information to recently published work on INF2 
function in the secretory pathway. In polarized cell lines such as 
HepG2 and MDCK cells, INF2 plays a role in basolateral-to-apical 
transcytosis (Madrid et al., 2010). In Jurkat T cells, INF2 plays a role 
in the transport of LCK kinase to the plasma membrane (Andres-
Delgado et al., 2010). In both cases, INF2’s function depends on 
interaction with a member of the MAL family of proteins—integral 
membrane proteins that localize to the trans-Golgi and endosomal 
pathway and have been previously shown to be important in Golgi-
to-apical transport in epithelial cells (Millan et al., 1997; Puertollano 
and Alonso, 1999).
To interpret mechanistic roles for INF2 in these processes, an un-
derstanding of the splice variants present in the particular cells in 
question is crucial. The INF2/MAL interaction requires INF2 se-
quence C-terminal to the DAD (Andres-Delgado et al., 2010; 
Madrid et al., 2010), but both CAAX and non-CAAX variants can in-
teract by two-hybrid assay, so in principle either splice variant could 
act in the MAL pathway. Our study reveals that the non-CAAX vari-
ant predominates in Jurkat cells. Live-cell microscopy of MAL and 
Lck dynamics in Jurkat cells shows vesicles emanating from intense 
pericentriolar staining and moving to the periphery (Andres-Delgado 
et al., 2010). In the INF2 knockdown cells, the pericentriolar staining 
persists, but vesicles containing MAL and Lck no longer move to the 
periphery. We wonder whether the transport defect is due in part to 
a Golgi defect, in addition to roles on endosomes in these cells.
MATERIALS AND METHODS
DNA constructs
Human INF2 ORF clone (SC313010) was obtained from OriGene 
(Rockville, MD). The gene was amplified using a GC-RICH PCR sys-
tem (Roche, Indianapolis, IN) and subcloned into eGFP-C1 vector 
(Clontech, Mountain View, CA) between XhoI and EcoRI sites. Sim-
ilarly, INF2–full-CAAX (amino acids 1–1249) and INF2–full-non-
CAAX (amino acids 1–1240) were generated by PCR and cloned 
into eGFP-C1 between XhoI and EcoRI sites. The C1246S mutation 
was made in the INF2–full-CAAX construct using QuikChange mu-
tagenesis (Stratagene, Santa Clara, CA). The mCherry-Sec61β was 
a kind gift from Jennifer Lippincott-Schwartz (National Institute of 
General Medical Sciences, Bethesda, MD). The GFP-ER construct, 
containing the ER-targeting sequence (amino acids 233–250) 
of budding yeast UBC6 (Wozniak et al., 2009), was a kind gift 
from Victoria Allan (University of Manchester, Manchester, United 
Kingdom).
RT-PCR
mRNA was isolated from cells using TRIzol reagent and cDNA syn-
thesized using SuperScript III as per the manufacturer’s protocol (In-
vitrogen, Carlsbad, CA). Because the CAAX exon is 5′ to the non-
CAAX exon and the non-CAAX exon is retained in the CAAX mRNA, 
we designed primers to detect both CAAX and non-CAAX isoforms 
by synthesizing a sense oligo in the exon preceding the CAAX exon 
and an antisense primer in the non-CAAX exon. The primers used 
for human INF2 were as follows: forward, 5′CGGTGACTCTGGGA-
GATGCTCAG3′; reverse, 5′TCACTTGGCCTTGGGCCTGGGCC3′; 
they gave fragments of 477 bases for CAAX and 420 bases for non-
CAAX. PCR reactions were conducted using Taq (Invitrogen).
Cell culture and plasmid transfections
NIH 3T3, HeLa, and U2OS cells were maintained in DMEM with 
4.5 g/l glucose, 584.0 mg/l l-glutamine, 110.0 mg/l sodium pyru-
vate, and 10% calf serum (Atlanta Biologicals, Lawrenceville, GA). 
NIH 3T3 cells were a kind gift from Gregg Gundersen (Columbia 
University, New York, NY). HeLa cells were obtained from the 
American Type Culture Collection (ATTC, Manassas, VA), and U2OS 
cells were a kind gift from Duane Compton (Dartmouth Medical 
School). Jurkat T leukemic cells were obtained from ATCC and cul-
tured in RPMI 1640 with l-glutamine, 5% fetal bovine serum (Atlanta 
Biologicals), 1 mM sodium pyruvate, 2.5 mg/ml glucose, and 
0.05 mM 2-mercaptoethanol. All cells were maintained at 37°C and 
5% CO2. Lipofectamine 2000 (Invitrogen) was used for all plasmid 
transfections as per the manufacturer’s protocol. A total of 100 ng of 
each plasmid DNA was used for all transfections, and the cells were 
analyzed 24 h posttransfection.
Antibodies
Polyclonal antibodies against INF2-FH1-FH2-C (amino acids 469–
1249) were raised in rabbits by Covance (Denver, PA) and affinity 
purified by using INF2-(C) (amino acids 941–1249) or INF2-(FH1-
FH2) (amino acids 469–940) coupled to Sulfolink (Pierce, Thermo 
Fisher Scientific, Rockford, IL). To generate splice variant–specific 
antibodies, human INF2 CAAX (acetyl-EEVPPDSDDNKTKKLC-
amide) or non-CAAX (acetyl-CQEGLRPRPKAK) peptides (Figure 2) 
coupled to KLH were injected into rabbits by Covance. The serum 
was purified using Sulfolink beads coupled to the CAAX or non-
CAAX peptides. A similar procedure was used for mouse splice vari-
ants, using acetyl-QEEFVPDSDDIKAKRLC-amide (CAAX) or acetyl-
CEGLRSRPKAK (non-CAAX).
Anti-tubulin (DM1-α; Sigma-Aldrich, St. Louis, MO) was used at 
1:10,000 dilution. GRP94 was detected using a rabbit polyclonal 
antibody (SPA-851; Stressgen, San Diego, CA) at 1:500 dilution. 
GM130 (ab52649; Abcam, Cambridge, MA) was stained using a 
polyclonal antibody at 1:300 dilution. Golgin-97 was detected using 
a monoclonal antibody (A21270; Invitrogen) at 1:300 dilution.
Secondary antibodies used were fluorescein and Texas red–con-
jugated anti–rabbit immunoglobulin G (IgG; Vector Laboratories, 
Burlingame, CA), Texas red (Vector Laboratories), and Alexa Fluor 
405–conjugated anti–mouse IgG (Invitrogen).
Fluorescence microscopy
Cells were fixed with 4% formaldehyde in phosphate-buffered sa-
line (PBS) for 1 h at room temperature. After washing with PBS, the 
cells were permeabilized on ice with 0.25% Triton X-100 in PBS for 
15 min. Cells were then washed with PBS prior to blocking with 2.5% 
calf serum in PBS for 1 h at room temperature. For INF2 staining, 
either unlabeled rabbit anti-INF2 at 5 μg/ml or Cy3-labeled rabbit 
anti-INF2 at 5 μg/ml was used. All primary staining was conducted 
for 1 h at room temperature. Following another wash with PBS, the 
secondary antibodies were added for 1 h at room temperature. For 
nuclear staining, DAPI was used for 10 min at 1:250,000 dilution. 
Actin was stained using 100 nM TRITC-phalloidin (Sigma-Aldrich). In 
cases in which Cy3-labeled anti-INF2 was used, cells were treated 
with the Cy3-labeled antibody subsequent to the secondary anti-
body incubation for 1 h. We found that the anti-INF2 antibody did 
not stain cells well after fixation in glutaraldehyde or methanol.
Images were captured using a Wave FX spinning disk confocal 
system (Quorum Technologies, Guelph, Canada; on a Nikon [Mel-
ville, NY] Eclipse microscope), using a 491-nm laser and 525/20 filter 
for GFP, a 403-nm laser and 460/20 filter for DAPI, and a 561-nm 
laser and 593/40 filter for Texas red. Images were acquired using 
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INF2 knockdown
All siRNAs were ordered from Applied Biosystems/Ambion 
(Austin, TX). The sequences were as follows: INF2 siRNA1, 
5′CCAUGAAGGCUUUCCGGGA3′; siRNA2; 5′CUUGGCAUCA-
CAUCAACA3′. Ambion negative control 1 (AM4635) was used as 
the control siRNA. U2OS cells were transfected using Lipofectamine 
RNAimax (Invitrogen) with 50 nM of the siRNA as per the manufac-
turer’s protocol. At 96 h posttransfection, the cells were used for 
analysis. NIH 3T3 cells were transfected using Lipofectamine 2000 
and PLUS Reagent (Invitrogen) with 200 nM siRNA.
Golgi dispersal analysis
Cells were fixed and stained for GM130 as described. Maximum 
intensity projections and 3D reconstructions of confocal z-stacks 
were used (0.2-μm slices, 20–30 z-slices, depending on cell height). 
Golgi structure was classified into three categories: compact (cover-
ing less than one-fourth of the nuclear perimeter), spread (between 
one-fourth and one-half of the nuclear perimeter), and dispersed 
greater than one-half of nuclear perimeter). Images were analyzed 
by two or three blinded observers, and the results are from three 
independent experiments.
U2OS synchronization and DNA content analysis
U2OS cells were plated in six-well plates and transfected with con-
trol siRNA or INF2 siRNA. Three days posttransfection, when the 
cells were ∼80% confluent, the medium was replaced with DMEM 
with 50 ng/ml nocodazole for 13–16 h. Mitotic cells were then iso-
lated by mitotic shake-off (gentle shake and tapping the plate). Mi-
totic cells were concentrated by centrifuging at 300 × g for 10 min, 
washing with fresh medium, and plating on poly-l-lysine–coated 
coverslips. After 6 h of culturing, all cells had entered G1 phase, as 
judged by DNA content analysis.
For DNA content analysis, cells were trypsinized and centrifuged 
5 min at 300 × g. The pellet was resuspended in cold PBS and cen-
trifuged again. Supernatant was removed, and the cell pellet was 
resuspended in 0.5 ml of cold PBS. For fixation, 4.5 ml of 70% ice-
cold ethanol was added dropwise to the cell suspension while vor-
texing at high speed. For staining, cells were washed twice with PBS 
and resuspended in 1 ml of propidium iodide/RNase staining solu-
tion containing 20 μg/ml propidium iodide, 0.1% Triton X-100, and 
0.2 mg/ml RNaseA (RNase A from Calbiochem) for 30 min at 23°C. 
The cells were analyzed by fluorescence-activated cell sorting using 
a FACSCalibur flow cytometer and Cell Quest software (BD Biosci-
ences, Rockville, MD). Populations of cells were gated according to 
the fluorescence intensity of PI staining.
MetaMorph and were processed using Nikon Elements and Photo-
shop CS (Adobe, San Jose, CA).
Digitonin permeabilization
U2OS cells were plated overnight onto 18-mm glass coverslips. 
Coverslips were washed several times in ice-cold PBS and then ex-
tracted with EB (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfo-
nic acid [HEPES], pH 7.5, 5 mM ethylene glycol tetraacetic acid, 
1 mM MgCl2, 1 mM dithiothreitol [DTT], 1 pill/50 ml Roche Com-
plete Protease Inhibitor without EDTA) with 0.15 mM digitonin 
(300410; Calbiochem, La Jolla, CA) on ice for the indicated time. 
Cells were then fixed and processed for fluorescence microscopy as 
described earlier.
Subcellular fractionation and Western blotting
The entire procedure was conducted on ice or at 4°C. Cells at ∼80% 
confluence were washed several times in iced PBS and once with EB 
and then were scraped in 1 ml of EB per 100-mm plate. Cells were 
homogenized 30 times in a stainless steel Dura-Grind (Wheaton In-
struments, Millville, NJ). KCl was added to 50 mM after homogeni-
zation. The homogenate was centrifuged 10 min at 2000 × g in a 
swinging bucket rotor. The supernatant (LSS) was centrifuged for 
20 min at 100,000 rpm (436,000 × g max) in a TLA120.2 centrifuge 
(Beckman Coulter, Brea, CA). Both pellets from the 2000 × g spin 
(LSP) and the 436,000 × g spin (HSP) were washed once in EB with 
50 mM KCl and then resuspended in EB plus 50 mM KCl. To prepare 
samples for SDS–PAGE, 50 μl was mixed with 34 μl of 10% SDS and 
1 μl of 1 M DTT, boiled 5 min, and cooled to 23°C; then 17 μl of 
300 mM of freshly made N-ethylmaleimide (NEM; Pierce) in water 
was added. Just before SDS–PAGE, the protein sample was mixed 
1:1 with 2× DB (250 mM Tris-HCl, pH 6.8, 2 mM EDTA, 20% glycerol, 
0.8% SDS, 0.02% bromophenol blue, 1000 mM NaCl, 4 M urea). We 
found that these sample preparation conditions were essential in 
obtaining a single protein band by Western blotting. If extraction 
was in normal SDS–PAGE buffer (containing 0.4% SDS, with no 
cysteine alkylation), we obtained multiple bands of apparent lower 
mass, as well as significant staining at very high apparent mass.
For IPs, U2OS cells (100-mm plate at 80% confluence) were lysed 
at room temperature in 1 ml of an IP buffer containing 100 mM 
HEPES (pH 7.4), 200 nM NaCl, 1 mM MgCl2, 4 mM EDTA, 2.5% 
SDS, Complete Protease Inhibitor, and 10 mM DTT. Lysates were 
immediately boiled for 5 min and cooled for 1 min in 23°C water; 
then 100 μl of 300 mM NEM (freshly made) was added. Thesit 
(P-9641; Sigma-Aldrich) was added to 8% and then the sample was 
centrifuged at 100,000 rpm for 20 min in a TLA120 rotor. The result-
ing homogenates were precleared using protein A–Sepharose 
beads (GE Biosciences, Piscataway, NJ) for 2 h at 4°C. The IPs were 
carried out overnight at 4°C using 2 μg of the appropriate antibody 
and 10 μl of protein A–Sepharose beads milliliter of homogenate. 
The beads were washed multiple times with IP buffer (lacking the 
SDS and DTT but containing 1% thesit) before being processed for 
SDS–PAGE and Western blotting as described.
Proteins were separated by 7.5% SDS–PAGE and transferred 
to a polyvinylidene fluoride membrane (Millipore, Billerica, MA). 
The membrane was blocked with TBS-T (20 mM Tris-HCl, pH 7.6, 
136 mM NaCl, and 0.1% Tween-20) containing 3% bovine serum 
albumin (Research Organics) for 1 h and then incubated with the 
primary antibody solution at 4°C overnight. After washing with TBS-
T, the membrane was incubated with horseradish peroxidase (HRP)-
conjugated secondary antibody (Bio-Rad, Hercules, CA) for 1 h at 
room temperature. Signals were detected by chemiluminescence 
(Pierce).
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